(Circulation. 2001;103:2851.)
© 2001 American Heart Association, Inc.
Basic Science Reports |
Phase 2 Early Afterdepolarization as a Trigger of Polymorphic Ventricular Tachycardia in Acquired Long-QT Syndrome
Direct Evidence From Intracellular Recordings in the Intact Left Ventricular Wall
From Main Line Health Heart Center, Wynnewood, Pa, and Merck Research Laboratory, West Point, Pa (J.W.).
Correspondence to Gan-Xin Yan, MD, PhD, Cardiology Foundation of Lankenau, 100 Lancaster Ave, Wynnewood, PA 19096. E-mail yanganxin{at}cs.com
Background—This study examined the role of phase 2 early afterdepolarization (EAD) in producing a trigger to initiate torsade de pointes (TdP) with QT prolongation induced by dl-sotalol and azimilide. The contribution of transmural dispersion of repolarization (TDR) to transmural propagation of EAD and the maintenance of TdP was also evaluated.
Methods and Results—Transmembrane action potentials from epicardium, midmyocardium, and endocardium were recorded simultaneously, together with a transmural ECG, in arterially perfused canine and rabbit left ventricular preparations. dl-Sotalol preferentially prolonged action potential duration (APD) in M cells dose-dependently (1 to 100 µmol/L), leading to QT prolongation and an increase in TDR. Azimilide, however, significantly prolonged APD and QT interval at concentrations from 0.1 to 10 µmol/L but shortened them at 30 µmol/L. Unlike dl-sotalol, azimilide (>3 µmol/L) increased epicardial APD markedly, causing a diminished TDR. Although both dl-sotalol and azimilide rarely induced EADs in canine left ventricles, they produced frequent EADs in rabbits, in which more pronounced QT prolongation was seen. An increase in TDR by dl-sotalol facilitated transmural propagation of EADs that initiated multiple episodes of spontaneous TdP in 3 of 6 rabbit left ventricles. Of note, although azimilide (3 to 10 µmol/L) increased APD more than dl-sotalol, its EADs often failed to propagate transmurally, probably because of a diminished TDR.
Conclusions—This study provides the first direct evidence from intracellular action potential recordings that phase 2 EAD can be generated from intact ventricular wall and produce a trigger to initiate the onset of TdP under QT prolongation.
Key Words: depolarization • action potentials • tachycardia
This article has been cited by other articles:
 |
|
 |
|
  C. Patel, J. F. Burke, H. Patel, P. Gupta, P. R. Kowey, C. Antzelevitch, and G.-X. Yan Is there a significant transmural gradient in repolarization time in the intact heart?: Cellular Basis of the T Wave: A Century of Controversy Circ Arrhythm Electrophysiol, February 1, 2009; 2(1): 80 - 88. [Full Text] [PDF]
|
|
|
|
 |
|
 T. G. Zhu, C. Patel, S. Martin, X. Quan, Y. Wu, J. F. Burke, M. Chernick, P. R. Kowey, and G.-X. Yan Ventricular transmural repolarization sequence: its relationship with ventricular relaxation and role in ventricular diastolic function Eur. Heart J., February 1, 2009; 30(3): 372 - 380. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J.-P. Couderc, S. Kaab, M. Hinterseer, S. McNitt, X. Xia, A. Fossa, B. M. Beckmann, S. Polonsky, and W. Zareba Baseline Values and Sotalol-Induced Changes of Ventricular Repolarization Duration, Heterogeneity, and Instability in Patients With a History of Drug-Induced Torsades de Pointes J. Clin. Pharmacol., January 1, 2009; 49(1): 6 - 16. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y. Mizukami, K. Ono, C.-K. Du, T. Aki, N. Hatano, Y. Okamoto, Y. Ikeda, H. Ito, K. Hamano, and S. Morimoto Identification and physiological activity of survival factor released from cardiomyocytes during ischaemia and reperfusion Cardiovasc Res, September 1, 2008; 79(4): 589 - 599. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. Due-Andersen, T. Hoi-Hansen, C. E. Larroude, N. V. Olsen, J. K. Kanters, F. Boomsma, U. Pedersen-Bjergaard, and B. Thorsteinsson Cardiac repolarization during hypoglycaemia in type 1 diabetes: impact of basal renin-angiotensin system activity Europace, July 1, 2008; 10(7): 860 - 867. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. Guo, L. Young, C. Patel, Z. Jiao, Y. Wu, T. Liu, P. R. Kowey, and G.-X. Yan Calcium-activated chloride current contributes to action potential alternations in left ventricular hypertrophy rabbit Am J Physiol Heart Circ Physiol, July 1, 2008; 295(1): H97 - H104. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. Due-Andersen, T. Hoi-Hansen, N. V. Olsen, C. E. Larroude, J. K. Kanters, F. Boomsma, U. Pedersen-Bjergaard, and B. Thorsteinsson Cardiac repolarization during hypoglycaemia and hypoxaemia in healthy males: impact of renin-angiotensin system activity Europace, February 1, 2008; 10(2): 219 - 226. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. Shantsila, T. Watson, and G. Y. Lip Drug-induced QT-interval prolongation and proarrhythmic risk in the treatment of atrial arrhythmias Europace, September 1, 2007; 9(suppl_4): iv37 - iv44. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. B. Huffaker, J. N. Weiss, and B. Kogan Effects of early afterdepolarizations on reentry in cardiac tissue: a simulation study Am J Physiol Heart Circ Physiol, June 1, 2007; 292(6): H3089 - H3102. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. Antoons, P. G. A. Volders, T. Stankovicova, V. Bito, M. Stengl, M. A. Vos, and K. R. Sipido Window Ca2+ current and its modulation by Ca2+ release in hypertrophied cardiac myocytes from dogs with chronic atrioventricular block J. Physiol., February 15, 2007; 579(1): 147 - 160. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. Thomas, M. J. Killeen, I. S. Gurung, P. Hakim, R. Balasubramaniam, C. A. Goddard, A. A. Grace, and C. L.-H. Huang Mechanisms of ventricular arrhythmogenesis in mice following targeted disruption of KCNE1 modelling long QT syndrome 5 J. Physiol., January 1, 2007; 578(1): 99 - 114. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. O. Verkerk, A. C.G. van Ginneken, G. Berecki, H. M. den Ruijter, C. A. Schumacher, M. W. Veldkamp, A. Baartscheer, S. Casini, T. Opthof, R. Hovenier, et al. Incorporated sarcolemmal fish oil fatty acids shorten pig ventricular action potentials Cardiovasc Res, June 1, 2006; 70(3): 509 - 520. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. A. Gintant, Z. Su, R. L. Martin, and B. F. Cox Utility of hERG Assays as Surrogate Markers of Delayed Cardiac Repolarization and QT Safety Toxicol Pathol, January 1, 2006; 34(1): 81 - 90. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. M. Fish, J. Brugada, and C. Antzelevitch Potential Proarrhythmic Effects of Biventricular Pacing J. Am. Coll. Cardiol., December 20, 2005; 46(12): 2340 - 2347. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Aiba, W. Shimizu, M. Inagaki, T. Noda, S. Miyoshi, W.-G. Ding, D. P. Zankov, F. Toyoda, H. Matsuura, M. Horie, et al. Cellular and ionic mechanism for drug-induced long QT syndrome and effectiveness of verapamil J. Am. Coll. Cardiol., January 18, 2005; 45(2): 300 - 307. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Noda, W. Shimizu, K. Satomi, K. Suyama, T. Kurita, N. Aihara, and S. Kamakura Classification and mechanism of Torsade de Pointes initiation in patients with congenital long QT syndrome Eur. Heart J., December 1, 2004; 25(23): 2149 - 2154. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. M. Yue, J. R. Paisey, S. Robinson, T. R. Betts, P. R. Roberts, and J. M. Morgan Determination of Human Ventricular Repolarization by Noncontact Mapping: Validation With Monophasic Action Potential Recordings Circulation, September 14, 2004; 110(11): 1343 - 1350. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G.-X. Yan, A. Joshi, D. Guo, T. Hlaing, J. Martin, X. Xu, and P. R. Kowey Phase 2 Reentry as a Trigger to Initiate Ventricular Fibrillation During Early Acute Myocardial Ischemia Circulation, August 31, 2004; 110(9): 1036 - 1041. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. Stilli, R. Berni, L. Bocchi, M. Zaniboni, F. Cacciani, A. Sgoifo, and E. Musso Vulnerability to ventricular arrhthmias and heterogeneity of action potential duration in normal rats Exp Physiol, July 1, 2004; 89(4): 387 - 396. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. Antzelevitch, L. Belardinelli, L. Wu, H. Fraser, A. C. Zygmunt, A. Burashnikov, J. M. Di Diego, J. M. Fish, J. M. Cordeiro, R. J. Goodrow Jr, et al. Electrophysiologic Properties and Antiarrhythmic Actions of a Novel Antianginal Agent Journal of Cardiovascular Pharmacology and Therapeutics, March 1, 2004; 9(1_suppl): S65 - S83. [Abstract] [PDF]
|
|
|
|
|
|
G.-X. Yan, R. S. Lankipalli, J. F. Burke, S. Musco, and P. R. Kowey Ventricular repolarization components on the electrocardiogram: Cellular basis and clinical significance J. Am. Coll. Cardiol., August 6, 2003; 42(3): 401 - 409. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
V. A. Medina-Ravell, R. S. Lankipalli, G.-X. Yan, C. Antzelevitch, N. A. Medina-Malpica, O. A. Medina-Malpica, C. Droogan, and P. R. Kowey Effect of Epicardial or Biventricular Pacing to Prolong QT Interval and Increase Transmural Dispersion of Repolarization: Does Resynchronization Therapy Pose a Risk for Patients Predisposed to Long QT or Torsade de Pointes? Circulation, February 11, 2003; 107(5): 740 - 746. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. F. James and J. C. Hancox Sex, drugs and arrhythmia: are gender differences in risk of torsades de pointes simply a matter of testosterone? Cardiovasc Res, January 1, 2003; 57(1): 1 - 4. [Full Text] [PDF]
|
|
|
|
|
|
C. Antzelevitch Sympathetic modulation of the long QT syndrome Eur. Heart J., August 2, 2002; 23(16): 1246 - 1252. [PDF]
|
|
|
|
|
|
X. Xu, J. J. Salata, J. Wang, Y. Wu, G.-X. Yan, T. Liu, R. A. Marinchak, and P. R. Kowey Increasing IKs corrects abnormal repolarization in rabbit models of acquired LQT2 and ventricular hypertrophy Am J Physiol Heart Circ Physiol, August 1, 2002; 283(2): H664 - H670. [Abstract] [Full Text] [PDF]
|
|